Johnson & Johnson

American multinational pharmaceutical and medical device company

Johnson & Johnson ▸ Facts ▸ Comments ▸ News ▸ Videos

Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 40 on the 2023 Fortune 500 list of the largest United States corporations. In 2023, the company was ranked 40th in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 130,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato.

0 shares	Share Tweet Save Post Send

You Might Like

J&J denied extension of patent on TB drug, to benefit patients IndiaTimes - Published 4 months ago
After court win to make baby powder, J&J gives up licence Three years since ceasing production of its talc-based powders in the US and Canada, pharmaceutical giant Johnson and Johnson recently surrendered its licence to manufacture baby powder in its Mumbai.. IndiaTimes - Published 2 years ago
Johnson & Johnson agrees to pay $8.9bn to settle claims that talc caused cancer Johnson & Johnson (J&J) has agreed to pay almost $9bn (£7.2bn) to settle tens of thousands of lawsuits alleging its talc caused cancer. Sky News - Published 2 years ago

Johnson & Johnson’s set to lose patent on key TB drug in July In one of the most-watched patent cases in recent times, the Indian Patent Office on Thursday rejected American giant Johnson & Johnson’s (J&J) attempt to extend its monopoly on life-saving TB drug.. IndiaTimes - Published 2 years ago
HC quashes J&J baby powder manufacture ban over FDA test delay IndiaTimes - Published 2 years ago